Common claim · overstated
"Reishi boosts immunity."
Too vague; the paper measured specific immune markers.
Better interpretation
Better: Ganoderma lucidum showed immune-marker signals at a defined dose in dogs.
This is concrete and source-aligned.
RESEARCH CORNER
Dogs - Reishi Nutrition Study
Kayser et al. 2024: Reishi, Immune Markers, and Ganoderma Claims in Dogs
Reishi can sound either ancient and mystical or aggressively biohacked. Kayser 2024 is better than both. It tested Ganoderma lucidum in adult beagles and found an immune-marker signal at the highest dose, while also reporting what did not change.
Executive Summary
SHOPPER TRANSLATION - 60-SEC READ
- 1 This is dog-specific reishi evidence. It studied Ganoderma lucidum supplementation in adult beagles, not only human or rodent mushroom data.
- 2 The main positive signal was immune-related. The highest-dose group showed higher rabies vaccine-specific serum IgG after vaccination and trends in immune-cell measures.
- 3 The null results matter. The study did not show broad changes in digestibility, fecal microbial DNA, or skin/coat health.
- 4 The claim boundary is clear. Immune support is not disease prevention, infection protection, or vaccine replacement.
- 5 Use it as a label filter. Ask for mushroom species, dose, extract/form, testing, and specific immune-support language.
Quick answers
What did Kayser et al. 2024 test?
It tested daily top-dressed Ganoderma lucidum supplementation at 0, 5, 10, and 15 mg/kg body weight in adult beagles.
What did it find?
The highest-dose group showed immune-marker signals, including higher rabies vaccine-specific serum IgG after vaccination.
Did it change everything?
No. The study reported no broad impact on overall health, macronutrient digestibility, fecal microbial DNA, or skin/coat health.
Does it prove immune protection?
No. Immune markers are not disease prevention or treatment claims.
How does La Petite Labs use it?
We use it as a functional-ingredient and immune-support reference for careful pathway language, not as disease-proof marketing.
Functional properties of Ganoderma lucidum supplementation in canine nutrition
§I·Study at a Glance
Forty adult beagles received top-dressed Ganoderma lucidum at different mg/kg doses. The 15 mg/kg group showed signals such as higher rabies vaccine-specific serum IgG after vaccination, while overall health, digestibility, fecal microbial DNA, and skin/coat health were not negatively affected or clearly changed in broad ways.
Grade B· controlled feeding studyRelevance · HighMisuse risk · Medium
Plain-English Boundary
What a product is allowed to take from this paper.
This paper supports dog-specific immune-support plausibility for a defined reishi protocol. It does not support disease-protection or vaccine-like claims.
I · Supports
Strongest fair reading
- Ganoderma lucidum can be studied in canine nutrition with measurable immune-related endpoints.
- The highest-dose group showed a vaccine-specific IgG signal after vaccination.
- The study reported no detrimental effect on macronutrient digestibility under its protocol.
- Mushroom claims should be species-, form-, and dose-specific.
§II.A · cite as #boundary-supports
II · Suggests
Useful shopping implications
- Ask whether a mushroom product names Ganoderma lucidum and its dose.
- Look for immune-support language tied to markers, not disease protection.
- Treat null findings as useful: not every body system changed.
- Expect quality controls for botanicals and mushroom-derived materials.
§II.B · cite as #boundary-suggests
III · Does not prove
What it does not prove
- It does not prove reishi prevents infection or disease.
- It does not replace vaccination or veterinary care.
- It does not prove skin/coat or microbiome benefits.
- It does not test Hollywood Elixir or a finished multi-ingredient formula.
§II.C · cite as #boundary-does-not-prove
IV · Claims to avoid
Language to distrust
- "Boosts immunity" without saying what that means.
- "Protects against disease" based on immune markers.
- "Replaces vaccines" or similar language.
- Mushroom marketing that omits species, form, dose, and testing.
§II.D · cite as #boundary-avoid
§III · What Was Tested
What the researchers actually tested
Kayser 2024 tested a defined mushroom ingredient in dogs.
Forty adult beagles were assigned to control or Ganoderma lucidum groups at 5, 10, or 15 mg/kg body weight. The supplement was top-dressed after feeding. After a control adaptation period, dogs received the treatment for 28 days, with vaccination during the study and blood sampling over time.
That makes the paper useful because it is dog-specific and endpoint-specific. It is not a generic reishi myth page.
Figure 1
Four-dose canine reishi design
Adult beagles received top-dressed Ganoderma lucidum for 28 days.
Source: Kayser et al. 2024Figure is a La Petite Labs editorial visualization of the paper design; it is not a reproduction from the article.
§IV · What Was Found
What the paper found
The immune-marker signal appeared strongest at 15 mg/kg.
The authors reported higher rabies vaccine-specific serum IgG in the 15 mg/kg group after vaccination, along with trends in immune-cell measures such as B-cell MHC-II and phagocytosis patterns.
Just as important, the study did not report broad disruption of macronutrient digestibility, overall health, fecal microbial DNA, or skin/coat health. That mixed specificity is the trustworthy part.
Figure 2
The signal was specific, not global
Immune marker signal at high dose; several broad outcomes did not shift.
Source: Kayser et al. 2024Simplified editorial summary. Read the cited paper before using these data in formal claims.
Figure 3
What transfers to the product shelf
Immune-support specificity is the buyer lesson.
Source: La Petite Labs interpretationThis is a claim-boundary aid, not veterinary advice and not a product efficacy claim.
§V · What It Does Not Prove
What no product should claim from this paper
Immune markers are not disease protection.
The paper does not prove that reishi prevents infections, treats illness, replaces vaccination, or broadly "boosts" immunity. It also does not prove skin/coat benefits, microbiome remodeling, or finished-product efficacy.
The responsible translation is narrower: Ganoderma lucidum has dog-specific immune-support data at a defined dosing protocol.
§VI · Why It Matters
Why the paper still deserves attention
Mushroom ingredients are everywhere, but dog-specific data are thinner than the marketing suggests.
This study gives shoppers a better way to read the category. It asks for species, dose, endpoint, and what did not change. That is much more useful than "ancient superfood" language.
For brands, it raises the bar: do not say immune protection when the paper measured immune markers.
§VII · Shopping Translation
How this should change your shopping
Read mushroom claims with a dose-and-endpoint lens.
- Ask which mushroom. Reishi, turkey tail, lion's mane, and blends are not interchangeable.
- Ask the form and amount. Extract, powder, beta-glucan standardization, and mg/kg logic all matter.
- Ask the endpoint. Immune marker, stool quality, cognition, and skin/coat are different claims.
- Ask for quality controls. Botanicals need contaminant and identity testing.
§VIII · Supplement Relevance
Where supplements can honestly fit
Functional ingredients can support immune-aging pathways when claims stay precise.
Hollywood Elixir is designed around disclosed aging-biology support, including antioxidant, mitochondrial, NAD+, and immune-balance relevant lanes. This paper is useful for thinking about functional ingredient discipline, not for claiming disease protection.
§IX · Commercial Translation
How brands turn the evidence into product claims
The common overreach is "immune boost."
That phrase is usually too vague. Does the brand mean vaccine response marker, innate immune cell trend, inflammation balance, infection resistance, allergy support, or something else?
The better page says exactly what the study measured, what dose was used, and which outcomes did not change.
§X· Commercial honesty ·Claim Decoder
Marketing shortcuts, translated.
A quick read on the claims a pet parent is likely to see while shopping.
Common claim · overstated
"Protects against illness."
Disease protection was not tested.
Better interpretation
Better: supports immune-system function markers.
Support language stays inside the evidence.
Common claim · overstated
"Also improves coat and microbiome."
The paper did not show broad skin/coat or fecal microbial DNA changes.
Better interpretation
Better: report the null findings clearly.
Null findings sharpen credibility.
§XI· Commercial honesty ·Marketing Translation
What this means on a supplement page.
Use this as a shopper decoder: the idea can be useful, but the claim still has to stay honest.
| Concept | Common claim | Better interpretation | Caution | LPL system |
|---|---|---|---|---|
| Reishi species | "Mushroom blend." | Name Ganoderma lucidum and dose/form. | Mushroom species are not interchangeable. | Hollywood Elixir |
| Immune marker | "Immune protection." | Frame as support for immune markers or immune balance. | Do not imply disease prevention. | LPL-01 |
| Quality | "Ancient superfood." | Show identity, contaminants, and COA/testing logic. | Botanical quality varies. | COA Lookup |
| Outcome specificity | "Supports everything." | Say what changed and what did not. | Broad claims weaken the paper. | Research Library |
§XII· Commercial honesty ·Buyer Checklist
Questions to ask before citing Kayser et al. 2024
Use these questions before accepting any study-backed product claim.
- Does the product name Ganoderma lucidum or only mushroom blend?
- Is dose/form disclosed?
- Does the claim avoid infection/disease protection?
- Does it mention what the study did not show?
- Are botanical quality controls visible?
- Is the product itself tested or only inspired?
⌜§XIII·LPL Interpretation⌟
La Petite Labs' interpretation
We read Kayser 2024 as a good model for functional-ingredient discipline.
The paper is useful because it is dog-specific, dose-aware, and honest about mixed endpoints. That is exactly the standard shoppers should apply to immune-support claims.
Hollywood Elixir should be read through the same lens: disclosed actives, pathway explanation, testing visibility, and no disease-protection language.
LPL-01 STANDARDRead the LPL-01 Standard
§XIV·Related Reading
Keep learning without the marketing fog.
GUIDE
What Is Hollywood Elixir?
A plain-English guide to our daily aging-biology support system.
RUBRIC
Pet Longevity Supplement Rubric
The criteria we use when comparing longevity-support products.
STANDARD
LPL-01 Evidence Standard
Our rules for disclosure, testing, evidence boundaries, and product claims.
QUALITY
COA Lookup
Where third-party testing and lot-level documentation should be easy to find.
LIBRARY
Pet Nutrition Evidence Library
The full evidence archive of study briefs, claim boundaries, and shopping interpretations.
IMMUNE-SUPPORT SHOPPING LENS
Ask immune claims to be specific.
A useful product page should name the ingredient, dose, endpoint, and boundary instead of leaning on "boost" language.
§XV·FAQ
Questions careful immune-support shoppers ask
Short answers for the shopping questions this study usually creates.
What did Kayser et al. 2024 actually test?
It tested Ganoderma lucidum supplementation at 0, 5, 10, and 15 mg/kg body weight in adult beagles.
What was the main positive signal?
The highest-dose group showed immune-marker signals, including higher rabies vaccine-specific serum IgG after vaccination.
Did it improve skin and coat?
No broad skin/coat impact was reported in the study.
Does it prove disease protection?
No. Immune markers are not disease-prevention claims.
What should shoppers look for?
Look for mushroom species, form, dose, endpoint, and quality controls.
How does La Petite Labs use the paper?
We use it as a model for precise immune-support language, not as a disease claim.
§XVI·Glossary
Plain-English terms
Useful definitions for reading the study without turning it into marketing haze.
- Ganoderma lucidum
- The mushroom species commonly called reishi.
- Immune marker
- A measurable immune-system signal, such as antibody level or immune-cell measure.
- IgG
- An antibody class measured in blood; vaccine-specific IgG can reflect immune response to vaccination.
- Top-dressed
- Added onto food rather than baked into the base diet.
- mg/kg
- Milligrams per kilogram of body weight, a dose scaled to animal size.
- Immune support
- Support for normal immune function, not a claim to prevent or treat disease.
§XVII·References
Sources used for this translation
Primary paper first, followed by practical veterinary or nutrition references where relevant.
-
Functional properties of Ganoderma lucidum supplementation in canine nutrition[link ↗]
-
LPL-01 Standard[link ↗]
-
COA Lookup[link ↗]
Research Library is educational. It does not diagnose, treat, cure, or prevent disease, and it does not replace veterinary advice.
